Shingles, Zostavax vaccination and risk of developing dementia: a nested case–control study—results from the UK Biobank cohort
ObjectivesTo investigate the association between shingles and dementia, and between Zostavax vaccination and dementia.DesignNested case–control study.SettingsData were drawn from the UK Biobank cohort study with a total of 228 223 participants with Hospital Episodes Statistics and primary care linka...
Saved in:
Published in | BMJ open Vol. 11; no. 10; p. e045871 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
British Medical Journal Publishing Group
08.10.2021
BMJ Publishing Group LTD BMJ Publishing Group |
Series | Original research |
Subjects | |
Online Access | Get full text |
ISSN | 2044-6055 2044-6055 |
DOI | 10.1136/bmjopen-2020-045871 |
Cover
Abstract | ObjectivesTo investigate the association between shingles and dementia, and between Zostavax vaccination and dementia.DesignNested case–control study.SettingsData were drawn from the UK Biobank cohort study with a total of 228 223 participants with Hospital Episodes Statistics and primary care linkage health records.ParticipantsThe analyses included 2378 incident dementia cases and 225 845 controls. Inclusion criteria for incident cases were a dementia diagnosis 3 years or more after the first assessment date derived from all sources including International Classification of Diseases (ICD)-10, ICD-9, self-report and primary care linkage records. Subjects with no dementia code from all sources were coded as controls. Both shingles and Zostavax vaccination were investigated for their association with dementia risk.ResultsThere was a small but non-significant increase in the risk of dementia in subjects with shingles diagnosed 3 years or more prior to dementia diagnosis (OR: 1.088 with 95% CI: 0.978 to 1.211). In those subjects who had had Zostavax vaccination, the risk of dementia significantly decreased (OR: 0.808 with 95% CI: 0.657 to 0.993).ConclusionA history of shingles was not associated with an increased risk of dementia. In subjects who were eligible for the immunisation and vaccinated with Zostavax, we saw reduced risk of developing dementia. |
---|---|
AbstractList | ObjectivesTo investigate the association between shingles and dementia, and between Zostavax vaccination and dementia.DesignNested case–control study.SettingsData were drawn from the UK Biobank cohort study with a total of 228 223 participants with Hospital Episodes Statistics and primary care linkage health records.ParticipantsThe analyses included 2378 incident dementia cases and 225 845 controls. Inclusion criteria for incident cases were a dementia diagnosis 3 years or more after the first assessment date derived from all sources including International Classification of Diseases (ICD)-10, ICD-9, self-report and primary care linkage records. Subjects with no dementia code from all sources were coded as controls. Both shingles and Zostavax vaccination were investigated for their association with dementia risk.ResultsThere was a small but non-significant increase in the risk of dementia in subjects with shingles diagnosed 3 years or more prior to dementia diagnosis (OR: 1.088 with 95% CI: 0.978 to 1.211). In those subjects who had had Zostavax vaccination, the risk of dementia significantly decreased (OR: 0.808 with 95% CI: 0.657 to 0.993).ConclusionA history of shingles was not associated with an increased risk of dementia. In subjects who were eligible for the immunisation and vaccinated with Zostavax, we saw reduced risk of developing dementia. To investigate the association between shingles and dementia, and between Zostavax vaccination and dementia.OBJECTIVESTo investigate the association between shingles and dementia, and between Zostavax vaccination and dementia.Nested case-control study.DESIGNNested case-control study.Data were drawn from the UK Biobank cohort study with a total of 228 223 participants with Hospital Episodes Statistics and primary care linkage health records.SETTINGSData were drawn from the UK Biobank cohort study with a total of 228 223 participants with Hospital Episodes Statistics and primary care linkage health records.The analyses included 2378 incident dementia cases and 225 845 controls. Inclusion criteria for incident cases were a dementia diagnosis 3 years or more after the first assessment date derived from all sources including International Classification of Diseases (ICD)-10, ICD-9, self-report and primary care linkage records. Subjects with no dementia code from all sources were coded as controls. Both shingles and Zostavax vaccination were investigated for their association with dementia risk.PARTICIPANTSThe analyses included 2378 incident dementia cases and 225 845 controls. Inclusion criteria for incident cases were a dementia diagnosis 3 years or more after the first assessment date derived from all sources including International Classification of Diseases (ICD)-10, ICD-9, self-report and primary care linkage records. Subjects with no dementia code from all sources were coded as controls. Both shingles and Zostavax vaccination were investigated for their association with dementia risk.There was a small but non-significant increase in the risk of dementia in subjects with shingles diagnosed 3 years or more prior to dementia diagnosis (OR: 1.088 with 95% CI: 0.978 to 1.211). In those subjects who had had Zostavax vaccination, the risk of dementia significantly decreased (OR: 0.808 with 95% CI: 0.657 to 0.993).RESULTSThere was a small but non-significant increase in the risk of dementia in subjects with shingles diagnosed 3 years or more prior to dementia diagnosis (OR: 1.088 with 95% CI: 0.978 to 1.211). In those subjects who had had Zostavax vaccination, the risk of dementia significantly decreased (OR: 0.808 with 95% CI: 0.657 to 0.993).A history of shingles was not associated with an increased risk of dementia. In subjects who were eligible for the immunisation and vaccinated with Zostavax, we saw reduced risk of developing dementia.CONCLUSIONA history of shingles was not associated with an increased risk of dementia. In subjects who were eligible for the immunisation and vaccinated with Zostavax, we saw reduced risk of developing dementia. Objectives To investigate the association between shingles and dementia, and between Zostavax vaccination and dementia.Design Nested case–control study.Settings Data were drawn from the UK Biobank cohort study with a total of 228 223 participants with Hospital Episodes Statistics and primary care linkage health records.Participants The analyses included 2378 incident dementia cases and 225 845 controls. Inclusion criteria for incident cases were a dementia diagnosis 3 years or more after the first assessment date derived from all sources including International Classification of Diseases (ICD)-10, ICD-9, self-report and primary care linkage records. Subjects with no dementia code from all sources were coded as controls. Both shingles and Zostavax vaccination were investigated for their association with dementia risk.Results There was a small but non-significant increase in the risk of dementia in subjects with shingles diagnosed 3 years or more prior to dementia diagnosis (OR: 1.088 with 95% CI: 0.978 to 1.211). In those subjects who had had Zostavax vaccination, the risk of dementia significantly decreased (OR: 0.808 with 95% CI: 0.657 to 0.993).Conclusion A history of shingles was not associated with an increased risk of dementia. In subjects who were eligible for the immunisation and vaccinated with Zostavax, we saw reduced risk of developing dementia. To investigate the association between shingles and dementia, and between Zostavax vaccination and dementia. Nested case-control study. Data were drawn from the UK Biobank cohort study with a total of 228 223 participants with Hospital Episodes Statistics and primary care linkage health records. The analyses included 2378 incident dementia cases and 225 845 controls. Inclusion criteria for incident cases were a dementia diagnosis 3 years or more after the first assessment date derived from all sources including International Classification of Diseases (ICD)-10, ICD-9, self-report and primary care linkage records. Subjects with no dementia code from all sources were coded as controls. Both shingles and Zostavax vaccination were investigated for their association with dementia risk. There was a small but non-significant increase in the risk of dementia in subjects with shingles diagnosed 3 years or more prior to dementia diagnosis (OR: 1.088 with 95% CI: 0.978 to 1.211). In those subjects who had had Zostavax vaccination, the risk of dementia significantly decreased (OR: 0.808 with 95% CI: 0.657 to 0.993). A history of shingles was not associated with an increased risk of dementia. In subjects who were eligible for the immunisation and vaccinated with Zostavax, we saw reduced risk of developing dementia. |
Author | Dobson, Curtis Cant, Rachel Burns, Alistair Muir, Kenneth Itzhaki, Ruth Mekli, Krisztina Lophatananon, Artitaya |
AuthorAffiliation | 1 Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health , The University of Manchester , Manchester , UK 4 The Oxford Institute of Population Ageing , University of Oxford , Oxford , UK 3 Division of Neuroscience & Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health , The University of Manchester , Manchester , UK 2 Division of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health , The University of Manchester , Manchester , UK |
AuthorAffiliation_xml | – name: 1 Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health , The University of Manchester , Manchester , UK – name: 2 Division of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health , The University of Manchester , Manchester , UK – name: 3 Division of Neuroscience & Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health , The University of Manchester , Manchester , UK – name: 4 The Oxford Institute of Population Ageing , University of Oxford , Oxford , UK |
Author_xml | – sequence: 1 givenname: Artitaya orcidid: 0000-0003-0550-4657 surname: Lophatananon fullname: Lophatananon, Artitaya organization: Division of Population Health, Health Services Research and Primary Care,School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK – sequence: 2 givenname: Krisztina surname: Mekli fullname: Mekli, Krisztina organization: Division of Population Health, Health Services Research and Primary Care,School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK – sequence: 3 givenname: Rachel surname: Cant fullname: Cant, Rachel organization: Division of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK – sequence: 4 givenname: Alistair surname: Burns fullname: Burns, Alistair organization: Division of Neuroscience & Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK – sequence: 5 givenname: Curtis surname: Dobson fullname: Dobson, Curtis organization: Division of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK – sequence: 6 givenname: Ruth surname: Itzhaki fullname: Itzhaki, Ruth organization: The Oxford Institute of Population Ageing, University of Oxford, Oxford, UK – sequence: 7 givenname: Kenneth orcidid: 0000-0001-6429-988X surname: Muir fullname: Muir, Kenneth email: kenneth.muir@manchester.ac.uk organization: Division of Population Health, Health Services Research and Primary Care,School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34625411$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UkluFDEULaEgEkJOgIQssWFBEY81sECCiCEiEgvIho3lqbrdcdmN7WqRXcQV4IQ5Ce50B5Is4o2__n_v6f3hcbXjgzdV9RTBVwiR5lCOi7A0vsYQwxpS1rXoQbWHIaV1AxnbuRHvVgcpLWB5lPWM4UfVLqENZhShverX17n1M2fSS_A9pCxW4idYCaWsF9kGD4TXINp0BsIAtFkZF5YFX8LR-GzFayCANykbDZRI5vLitwo-x-BAypM-v7z4E02aXE5giGEEeW7A6WfwzgYp_BlQYR5iflI9HIRL5mD771enH95_O_pUn3z5eHz09qSWpYtcK9xrgRVqaIcbTQjGDPYaSsJIr7UcUNsoAU3JKSyhppARaQpHQ0YZlS3Zr443ujqIBV9GO4p4zoOw_CoR4oyLmK1yhktKCRRwwJoiSlosNaK4QRr1kLa4oUXrzUZrOcnRaFWGEYW7JXq74u2cz8KKdwxSwroi8GIrEMOPqUyQjzYp45zwJkyJY9bBFkKESYE-vwNdhCn6MiqOm4ahsvxu3d2zm47-WbledQH0G4CKIaVoBq5svlpyMWgdR5CvL4tvL4uvL4tvLqtwyR3utfz9rMMNqxT_e76P8RdOb-TM |
CitedBy_id | crossref_primary_10_1007_s10072_023_07038_7 crossref_primary_10_1016_j_bbi_2024_07_026 crossref_primary_10_1126_scisignal_ado6430 crossref_primary_10_1186_s12889_023_16768_4 crossref_primary_10_3233_JAD_221231 crossref_primary_10_1093_qjmed_hcae103 crossref_primary_10_3233_JAD_220361 crossref_primary_10_3390_ijms26020508 crossref_primary_10_1016_j_vaccine_2024_126673 crossref_primary_10_3233_JAD_220287 crossref_primary_10_1016_j_exger_2024_112411 crossref_primary_10_1080_14760584_2023_2185223 crossref_primary_10_3233_JAD_220955 crossref_primary_10_1186_s13195_024_01418_7 crossref_primary_10_5692_clinicalneurol_cn_002047 crossref_primary_10_1016_j_neuron_2022_12_029 crossref_primary_10_1186_s13195_024_01511_x crossref_primary_10_1002_cdt3_50 crossref_primary_10_3233_JAD_231323 crossref_primary_10_1016_j_bbih_2024_100743 crossref_primary_10_1016_j_celrep_2024_115109 crossref_primary_10_1097_MD_0000000000034503 crossref_primary_10_1007_s40520_023_02409_8 crossref_primary_10_1212_WNL_0000000000200709 crossref_primary_10_1002_brb3_3407 crossref_primary_10_1007_s11920_024_01514_3 crossref_primary_10_1016_j_bbi_2024_06_020 crossref_primary_10_1080_14737175_2023_2244162 crossref_primary_10_3390_v16010133 crossref_primary_10_3389_fimmu_2022_872542 crossref_primary_10_4103_ds_DS_D_24_00055 crossref_primary_10_1007_s10072_022_06280_9 |
Cites_doi | 10.1371/journal.pone.0096779 10.1093/aje/kwx246 10.1002/psb.1688 10.1007/s10654-019-00499-1 10.1016/j.jalz.2019.07.014 10.4088/JCP.16m11312 10.1007/s004150050078 10.1016/S0140-6736(20)30367-6 10.1002/jmv.1890330403 10.1016/S0140-6736(96)10149-5 10.1016/0002-9343(62)90179-1 10.1056/NEJMc2008597 10.1007/s13365-020-00830-7 10.1007/s00415-002-0874-2 10.2147/CLEP.S282475 10.1002/jmv.23397 10.1016/S1473-3099(03)00857-0 10.1136/bmjopen-2018-023502 10.1371/journal.pone.0188490 10.1186/s13195-017-0241-2 10.1177/15333175211006504 10.1016/s0140-6736(96)10149-5 |
ContentType | Journal Article |
Copyright | Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 |
Copyright_xml | – notice: Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. – notice: 2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 |
DBID | 9YT ACMMV AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 88G 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR BTHHO CCPQU COVID DWQXO FYUFA GHDGH GNUQQ K9- K9. KB0 M0R M0S M1P M2M NAPCQ PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PSYQQ Q9U 7X8 5PM DOA |
DOI | 10.1136/bmjopen-2020-045871 |
DatabaseName | BMJ Open Access Journals BMJ Journals:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central BMJ Journals ProQuest One Community College Coronavirus Research Database ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Consumer Health Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Consumer Health Database ProQuest Health & Medical Collection PML(ProQuest Medical Library) Psychology Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Family Health (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest Family Health ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition BMJ Journals ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: ACMMV name: BMJ Journals:Open Access url: https://journals.bmj.com/ sourceTypes: Publisher – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
EISSN | 2044-6055 |
ExternalDocumentID | oai_doaj_org_article_b4430a0f2d414372bd14261d19047264 PMC8504358 34625411 10_1136_bmjopen_2020_045871 bmjopen |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | United Kingdom United Kingdom--UK |
GeographicLocations_xml | – name: United Kingdom – name: United Kingdom--UK |
GrantInformation_xml | – fundername: The Advantage Foundation grantid: 106529/190624 – fundername: Medical Research Council grantid: MC_PC_17228 – fundername: Medical Research Council grantid: MC_QA137853 – fundername: ; grantid: 106529/190624 |
GroupedDBID | --- 4.4 53G 5VS 7RV 7X7 7~R 88E 8FI 8FJ 9YT ABUWG ACGFS ACMMV ADBBV AENEX AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BKNYI BPHCQ BTFSW BTHHO CCPQU DIK DWQXO EBS FYUFA GNUQQ GROUPED_DOAJ GX1 H13 HMCUK HYE HZ~ K9- KQ8 M0R M1P M2M M48 M~E NAPCQ O9- OK1 PGMZT PHGZT PIMPY PQQKQ PROAC PSQYO PSYQQ RHI RMJ RPM UKHRP AAYXX ADRAZ BVXVI CITATION EJD PHGZM CGR CUY CVF ECM EIF NPM PJZUB PPXIY 3V. 7XB 8FK COVID K9. PKEHL PQEST PQUKI Q9U 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-b605t-c29da2c164826d3322509d0b3539ddbf176ca0e09dc2b0d4053be29dd05454b73 |
IEDL.DBID | M48 |
ISSN | 2044-6055 |
IngestDate | Wed Aug 27 01:20:31 EDT 2025 Thu Aug 21 18:05:29 EDT 2025 Thu Sep 04 22:04:15 EDT 2025 Fri Jul 25 10:51:14 EDT 2025 Mon Jul 21 06:03:14 EDT 2025 Tue Jul 01 02:44:32 EDT 2025 Thu Apr 24 23:00:17 EDT 2025 Thu Apr 24 22:50:05 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | epidemiology dementia public health |
Language | English |
License | This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b605t-c29da2c164826d3322509d0b3539ddbf176ca0e09dc2b0d4053be29dd05454b73 |
Notes | Original research ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 CD, RI and KM are joint senior authors. |
ORCID | 0000-0001-6429-988X 0000-0003-0550-4657 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1136/bmjopen-2020-045871 |
PMID | 34625411 |
PQID | 2665145887 |
PQPubID | 2040975 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_b4430a0f2d414372bd14261d19047264 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8504358 proquest_miscellaneous_2580700123 proquest_journals_2665145887 pubmed_primary_34625411 crossref_citationtrail_10_1136_bmjopen_2020_045871 crossref_primary_10_1136_bmjopen_2020_045871 bmj_journals_10_1136_bmjopen_2020_045871 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-10-08 |
PublicationDateYYYYMMDD | 2021-10-08 |
PublicationDate_xml | – month: 10 year: 2021 text: 2021-10-08 day: 08 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London – name: BMA House, Tavistock Square, London, WC1H 9JR |
PublicationSeriesTitle | Original research |
PublicationTitle | BMJ open |
PublicationTitleAbbrev | BMJ Open |
PublicationTitleAlternate | BMJ Open |
PublicationYear | 2021 |
Publisher | British Medical Journal Publishing Group BMJ Publishing Group LTD BMJ Publishing Group |
Publisher_xml | – name: British Medical Journal Publishing Group – name: BMJ Publishing Group LTD – name: BMJ Publishing Group |
References | Thomas, Hall (R14) 2004; 4 Wetzel, Asholt, Herrmann (R17) 2002; 249 Westman, Berglund, Widén (R5) 2014; 9 Wilkinson, Schnier, Bush (R8) 2019; 34 Curran, Hunjan, El Ghachi (R13) 2019; 9 Grahn, Bauer, Silver (R18) 2013; 54 Helms, Kremer, Merdji (R23) 2020; 382 Stowe, Peek, Cutchin (R4) 2012; 84 Dowden (R7) 2018; 29 Choi, Park, Lim (R11) 2021; 36 Itzhaki, Lin, Shang (R3) 1997; 349 Ludvigsson, Appelros, Askling (R10) 2021; 13 Hokkanen, Launes, Poutiainen (R16) 1997; 244 Calvin, Wilkinson, Starr (R12) 2019; 15 Bubak, Beseler, Como (R6) 2020; 26 Jamieson, Maitland, Wilcock (R2) 1991; 33 Chen, Wu, Huang (R20) 2018; 79 Tsai, Cheng, Sheu (R19) 2017; 12 Fry, Littlejohns, Sudlow (R26) 2017; 186 McManus, Heneka (R24) 2017; 9 Livingston, Huntley, Sommerlad (R1) 2020; 396 Verreault, Laurin, Lindsay (R22) 2001; 165 Appelbaum, Kreps, Sunshine (R15) 1962; 32 Itzhaki, Dobson (R21) 2002; 167 2024102817410846000_11.10.e045871.14 2024102817410846000_11.10.e045871.1 2024102817410846000_11.10.e045871.15 2024102817410846000_11.10.e045871.8 2024102817410846000_11.10.e045871.9 Bubak (2024102817410846000_11.10.e045871.6) 2020; 26 Dowden (2024102817410846000_11.10.e045871.7) 2018; 29 2024102817410846000_11.10.e045871.4 Calvin (2024102817410846000_11.10.e045871.12) 2019; 15 2024102817410846000_11.10.e045871.2 2024102817410846000_11.10.e045871.3 Curran (2024102817410846000_11.10.e045871.13) 2019; 9 2024102817410846000_11.10.e045871.25 Wetzel (2024102817410846000_11.10.e045871.17) 2002; 249 Chen (2024102817410846000_11.10.e045871.20) 2018; 79 2024102817410846000_11.10.e045871.26 Ludvigsson (2024102817410846000_11.10.e045871.10) 2021; 13 Hokkanen (2024102817410846000_11.10.e045871.16) 1997; 244 Itzhaki (2024102817410846000_11.10.e045871.21) 2002; 167 Choi (2024102817410846000_11.10.e045871.11) 2021; 36 Westman (2024102817410846000_11.10.e045871.5) 2014; 9 Tsai (2024102817410846000_11.10.e045871.19) 2017; 12 Verreault (2024102817410846000_11.10.e045871.22) 2001; 165 McManus (2024102817410846000_11.10.e045871.24) 2017; 9 Helms (2024102817410846000_11.10.e045871.23) 2020; 382 Grahn (2024102817410846000_11.10.e045871.18) 2013; 54 |
References_xml | – volume: 9 year: 2014 ident: R5 article-title: Increased inflammatory response in cytomegalovirus seropositive patients with Alzheimer’s disease publication-title: PLoS One doi: 10.1371/journal.pone.0096779 – volume: 186 start-page: 1026 year: 2017 ident: R26 article-title: Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population publication-title: Am J Epidemiol doi: 10.1093/aje/kwx246 – volume: 29 start-page: 23 year: 2018 ident: R7 article-title: Is the UK shingles vaccination programme fit for the future? publication-title: Prescriber doi: 10.1002/psb.1688 – volume: 34 start-page: 557 year: 2019 ident: R8 article-title: Identifying dementia outcomes in UK Biobank: a validation study of primary care, hospital admissions and mortality data publication-title: Eur J Epidemiol doi: 10.1007/s10654-019-00499-1 – volume: 15 start-page: 1546 year: 2019 ident: R12 article-title: Predicting incident dementia 3-8 years after brief cognitive tests in the UK Biobank prospective study of 500,000 people publication-title: Alzheimer's & Dementia doi: 10.1016/j.jalz.2019.07.014 – volume: 36 year: 2021 ident: R11 article-title: Herpes zoster does not increase the risk of neurodegenerative dementia: a case-control study publication-title: American Journal of Alzheimer’s Disease and Other Dementias – volume: 79 year: 2018 ident: R20 article-title: Herpes zoster and dementia: a nationwide population-based cohort study publication-title: J Clin Psychiatry doi: 10.4088/JCP.16m11312 – volume: 165 start-page: 1495 year: 2001 ident: R22 article-title: Past exposure to vaccines and subsequent risk of Alzheimer's disease publication-title: CMAJ – volume: 244 start-page: 239 year: 1997 ident: R16 article-title: Subcortical type cognitive impairment in herpes zoster encephalitis publication-title: J Neurol doi: 10.1007/s004150050078 – volume: 396 start-page: 413 year: 2020 ident: R1 article-title: Dementia prevention, intervention, and care: 2020 report of the Lancet Commission publication-title: Lancet doi: 10.1016/S0140-6736(20)30367-6 – volume: 33 start-page: 224 year: 1991 ident: R2 article-title: Latent herpes simplex virus type 1 in normal and Alzheimer’s disease brains publication-title: J Med Virol doi: 10.1002/jmv.1890330403 – volume: 349 start-page: 241 year: 1997 ident: R3 article-title: Herpes simplex virus type 1 in brain and risk of Alzheimer’s disease publication-title: The Lancet doi: 10.1016/S0140-6736(96)10149-5 – volume: 32 start-page: 25 year: 1962 ident: R15 article-title: Herpes zoster encephalitis publication-title: Am J Med doi: 10.1016/0002-9343(62)90179-1 – volume: 382 start-page: 2268 year: 2020 ident: R23 article-title: Neurologic features in severe SARS-CoV-2 infection publication-title: N Engl J Med Overseas Ed doi: 10.1056/NEJMc2008597 – volume: 26 start-page: 422 year: 2020 ident: R6 article-title: Acute zoster plasma contains elevated amyloid, correlating with Aβ42 and amylin levels, and is amyloidogenic publication-title: J Neurovirol doi: 10.1007/s13365-020-00830-7 – volume: 249 start-page: 1612 year: 2002 ident: R17 article-title: Good cognitive outcome of patients with herpes zoster encephalitis: a follow-up study publication-title: J Neurol doi: 10.1007/s00415-002-0874-2 – volume: 54 start-page: 86 year: 2013 ident: R18 article-title: Diagnostic ophthalmology publication-title: Can Vet J – volume: 167 start-page: 13 year: 2002 ident: R21 article-title: Alzheimer's disease and herpes publication-title: CMAJ – volume: 13 start-page: 21 year: 2021 ident: R10 article-title: Adaptation of the Charlson comorbidity index for register-based research in Sweden publication-title: Clinical epidemiology doi: 10.2147/CLEP.S282475 – volume: 84 start-page: 1797 year: 2012 ident: R4 article-title: Reactivation of herpes simplex virus type 1 is associated with cytomegalovirus and age publication-title: J Med Virol doi: 10.1002/jmv.23397 – volume: 4 start-page: 26 year: 2004 ident: R14 article-title: What does epidemiology tell us about risk factors for herpes zoster? publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(03)00857-0 – volume: 9 year: 2019 ident: R13 article-title: Herpes zoster related healthcare burden and costs in immunocompromised (IC) and IC-free populations in England: an observational retrospective database analysis publication-title: BMJ Open doi: 10.1136/bmjopen-2018-023502 – volume: 12 year: 2017 ident: R19 article-title: Increased risk of dementia following herpes zoster ophthalmicus publication-title: PLoS One doi: 10.1371/journal.pone.0188490 – volume: 9 start-page: 14 year: 2017 ident: R24 article-title: Role of neuroinflammation in neurodegeneration: new insights publication-title: Alzheimers Res Ther doi: 10.1186/s13195-017-0241-2 – volume: 36 year: 2021 ident: 2024102817410846000_11.10.e045871.11 article-title: Herpes zoster does not increase the risk of neurodegenerative dementia: a case-control study publication-title: American Journal of Alzheimer’s Disease and Other Dementias doi: 10.1177/15333175211006504 – ident: 2024102817410846000_11.10.e045871.3 doi: 10.1016/s0140-6736(96)10149-5 – ident: 2024102817410846000_11.10.e045871.15 doi: 10.1016/0002-9343(62)90179-1 – volume: 382 start-page: 2268 year: 2020 ident: 2024102817410846000_11.10.e045871.23 article-title: Neurologic features in severe SARS-CoV-2 infection publication-title: N Engl J Med Overseas Ed doi: 10.1056/NEJMc2008597 – ident: 2024102817410846000_11.10.e045871.26 doi: 10.1093/aje/kwx246 – volume: 165 start-page: 1495 year: 2001 ident: 2024102817410846000_11.10.e045871.22 article-title: Past exposure to vaccines and subsequent risk of Alzheimer's disease publication-title: CMAJ – ident: 2024102817410846000_11.10.e045871.1 doi: 10.1016/S0140-6736(20)30367-6 – volume: 13 start-page: 21 year: 2021 ident: 2024102817410846000_11.10.e045871.10 article-title: Adaptation of the Charlson comorbidity index for register-based research in Sweden publication-title: Clinical epidemiology doi: 10.2147/CLEP.S282475 – volume: 15 start-page: 1546 year: 2019 ident: 2024102817410846000_11.10.e045871.12 article-title: Predicting incident dementia 3-8 years after brief cognitive tests in the UK Biobank prospective study of 500,000 people publication-title: Alzheimer's & Dementia doi: 10.1016/j.jalz.2019.07.014 – volume: 26 start-page: 422 year: 2020 ident: 2024102817410846000_11.10.e045871.6 article-title: Acute zoster plasma contains elevated amyloid, correlating with Aβ42 and amylin levels, and is amyloidogenic publication-title: J Neurovirol doi: 10.1007/s13365-020-00830-7 – volume: 12 year: 2017 ident: 2024102817410846000_11.10.e045871.19 article-title: Increased risk of dementia following herpes zoster ophthalmicus publication-title: PLoS One doi: 10.1371/journal.pone.0188490 – ident: 2024102817410846000_11.10.e045871.14 doi: 10.1016/S1473-3099(03)00857-0 – volume: 79 year: 2018 ident: 2024102817410846000_11.10.e045871.20 article-title: Herpes zoster and dementia: a nationwide population-based cohort study publication-title: J Clin Psychiatry doi: 10.4088/JCP.16m11312 – volume: 9 year: 2014 ident: 2024102817410846000_11.10.e045871.5 article-title: Increased inflammatory response in cytomegalovirus seropositive patients with Alzheimer’s disease publication-title: PLoS One doi: 10.1371/journal.pone.0096779 – volume: 9 start-page: 14 year: 2017 ident: 2024102817410846000_11.10.e045871.24 article-title: Role of neuroinflammation in neurodegeneration: new insights publication-title: Alzheimers Res Ther doi: 10.1186/s13195-017-0241-2 – volume: 54 start-page: 86 year: 2013 ident: 2024102817410846000_11.10.e045871.18 article-title: Diagnostic ophthalmology publication-title: Can Vet J – ident: 2024102817410846000_11.10.e045871.8 doi: 10.1007/s10654-019-00499-1 – volume: 29 start-page: 23 year: 2018 ident: 2024102817410846000_11.10.e045871.7 article-title: Is the UK shingles vaccination programme fit for the future? publication-title: Prescriber doi: 10.1002/psb.1688 – ident: 2024102817410846000_11.10.e045871.2 doi: 10.1002/jmv.1890330403 – ident: 2024102817410846000_11.10.e045871.9 – volume: 244 start-page: 239 year: 1997 ident: 2024102817410846000_11.10.e045871.16 article-title: Subcortical type cognitive impairment in herpes zoster encephalitis publication-title: J Neurol doi: 10.1007/s004150050078 – ident: 2024102817410846000_11.10.e045871.4 doi: 10.1002/jmv.23397 – volume: 249 start-page: 1612 year: 2002 ident: 2024102817410846000_11.10.e045871.17 article-title: Good cognitive outcome of patients with herpes zoster encephalitis: a follow-up study publication-title: J Neurol doi: 10.1007/s00415-002-0874-2 – volume: 167 start-page: 13 year: 2002 ident: 2024102817410846000_11.10.e045871.21 article-title: Alzheimer's disease and herpes publication-title: CMAJ – volume: 9 year: 2019 ident: 2024102817410846000_11.10.e045871.13 article-title: Herpes zoster related healthcare burden and costs in immunocompromised (IC) and IC-free populations in England: an observational retrospective database analysis publication-title: BMJ Open doi: 10.1136/bmjopen-2018-023502 – ident: 2024102817410846000_11.10.e045871.25 |
SSID | ssj0000459552 |
Score | 2.462471 |
Snippet | ObjectivesTo investigate the association between shingles and dementia, and between Zostavax vaccination and dementia.DesignNested case–control... To investigate the association between shingles and dementia, and between Zostavax vaccination and dementia. Nested case-control study. Data were drawn from... To investigate the association between shingles and dementia, and between Zostavax vaccination and dementia.OBJECTIVESTo investigate the association between... Objectives To investigate the association between shingles and dementia, and between Zostavax vaccination and dementia.Design Nested case–control... |
SourceID | doaj pubmedcentral proquest pubmed crossref bmj |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e045871 |
SubjectTerms | Age Alzheimer's disease Biobanks Biological Specimen Banks Brain research Case-Control Studies Chicken pox Codes Cohort Studies Cytomegalovirus Datasets Dementia Dementia - epidemiology Epidemiology Herpes viruses Herpes Zoster Herpes Zoster Vaccine Humans Immunization Investigations Primary care public health United Kingdom - epidemiology Vaccination Vaccines |
SummonAdditionalLinks | – databaseName: BMJ Open Access Journals dbid: 9YT link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NbtQwEB61RaoqVQjKTwMFGYkDh6Z1_JNsuFFEVYHgQlcqXCLHdkphSdButuJY8QrwhH0SZpxkyyJUcUqUjC0n4xl_Mx7PADwdWelELmxsKVRcZd6hHpQiTlOvUDVIj1eKtniXHo3V6xN9sgJiOAtTfv1MZaP28NqdaKAcTXW7nyQo3_uetvWyZI9c06twg3JxURhf_uF44VdBilyHQjuCKxUjWtd9sqFEpkP3ODcERTVSZxuwLhVaAYqKCK0iwdIKFRL5_wt9_h1E-ceqdHgLbvZwkr3o-H8bVny9Betv-w3zLdjs3HKsO210B368J4_TxM922ccGgeG5-c7OjUXiwCFmasco2pw1Fbs6T4W3IarIPGeG1cFDyiwuf5cXP_tQdxbS1F5e_ELrfT5pZ4yOrTAEl2z8hh2codKovzAqxjtt78L48NXxy6O4L8MQl_j32tiK3Blh0a5CU8RJ0gA8d7yUWubOlVWSpdZwj8-sKLlDBChLj20cokGtykzeg7W6qf02MGm5lFp5622lsio12LNDm0lnPBNOpRE8QwYUvRjNimChyLTo2VYQ24qObRGIgUuF7dOZU1WNyfWNdheNvnXZPK4nPyD2L0gpFXd40ExPi16yi1IpyQ2vcPwJbYKWLiGz1CHSUhnCzQh2hslz9WEIixCpatTwETxZvEbJpu0aU_tmjjR6xLOAeSO43821xUiGGRtBtjQLl4a6_KY--xSyh48oZ50ePfj_X_0QNgRF8oTIxx1Ya6dz_wihWFs-DrL3G2XZLkU priority: 102 providerName: BMJ Publishing Group Ltd – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZKDxUXVGiB0IKMxKGHRnX8iBNuFFFVoHKBlSoukV8RbbdZ1M1WHCv-AvzC_hJmHHe7i1C5cErkR-RkxuNv4s8zhLyqnPC85i53SBWXOniwg4LnZRkkmAYR4Ipsi4_l4Ui-P1bHC6m-kBM2hAcePtyelVIww1ruZYF7TNYXiPo9LGRSw2qO1pfVbMGZijZYqlopnsIMFaLcs-enmI8KtIIjn1FVeGj-HpQuLUgxbv_fwOafnMmFRehgnTxI6JG-GUb9kKyE7hFZO0r74xvkxyf8oTQO0136ZQK479J8p5fGQWUUADWdp0gmp5OW3h6XgttIGjKvqaFd_AFKHaxu11c_E5Odxii011e_wDmfjfspxVMpFLAjHX2g-ydgE7ozirl2L_pNMjp49_ntYZ6yLOQWXJk-d7z2hjtwm8DT8AInOKs9s0KJ2nvbFrp0hgUoc9wyDwBP2AB9PIA9Ja0Wj8lqN-nCU0KFY0IoGVxwrdRtaeDJHlwipZkG-ZUZ2YEP3qRZMm2iAyLKJsmmQdk0g2wywm-k0rgUrRyTZozv7rQ77_RtCNZxd_N9FPe8KUbajgWgf03Sv-Zf-peR7RtluX0xQD0ARBUY8Iy8nFfDxMXdGNOFyQzaqIrpCGkz8mTQrflIhAS3VBYwQr2kdUtDXa7pTr7G4OAVhqRT1bP_8W5b5D5HCk-kPG6T1f5iFp4DBuvtizjdfgMl1y6H priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9NAEF7RIiEuqLwNBS0SBw61au_Da_eCKKKqQHCBSBEXa1-GQrBL4lQ9Vv0L8Av7S5jZbByCUE6O9mGNMzsz3-zOzhDyvLTcsYrZ1GKouFDegR7kLC0KL0A1cA9PjLb4UByPxNuxHMcNt1kMq1zqxKCoXWdxj3wfDAnYdgky8fL0Z4pVo_B0NZbQ2CLXc0AiWLpBjdWwxwJwpZKSxWRDOS_2zY9vWJUK1gbDqEZZ4tX5LWhdM0she___IOe_kZN_maKjHXIrYkj6asH02-Sab--QG-_jKfldcvkRt5UmfrZHP3eA_s70OT3TFjoDG6huHcWQcto1dHVpCn6G0CF9QDVtwzYotWDjri5-xXh2GnLRXl38Bhd9PulnFO-mUECQdPSOHp6AZmi_U6y4O-3vkdHRm0-vj9NYayE14ND0qWWV08yC8wT-huMo5lnlMsMlr5wzTa4KqzMPbZaZzAHM48bDHAeQTwqj-H2y3Xatf0gotxnnUnjrbSNUU2h4swPHSKpMMSeKhLyAP7yOsjKrgxvCizrypkbe1AveJIQtuVLbmLMcS2dMNk_aGyadLlJ2bB5-iOwehmK-7dDQTb_UUXxrIwTPdNYA_TmedBqXo-_pAE4JBZgyIbvLxbL6sNWSTcizoRvEF89kdOu7OYyRZaYCsE3Ig8XaGijhApxTkQOFam3VrZG63tOefA0pwktMTCfLR5vJekxuMgzRCSGNu2S7n879E8BYvXkaBOkP5M4oEQ priority: 102 providerName: ProQuest |
Title | Shingles, Zostavax vaccination and risk of developing dementia: a nested case–control study—results from the UK Biobank cohort |
URI | https://bmjopen.bmj.com/content/11/10/e045871.full https://www.ncbi.nlm.nih.gov/pubmed/34625411 https://www.proquest.com/docview/2665145887 https://www.proquest.com/docview/2580700123 https://pubmed.ncbi.nlm.nih.gov/PMC8504358 https://doaj.org/article/b4430a0f2d414372bd14261d19047264 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZKKyEuiDeBsjISBw5dSPyIEySEulVLBdoKQRctXKL4ESgsCexmq3Kr-AvwC_tLmPF6tywqPXFJIj8iJ-Oxv7E_zxDyIDPcspyZrkGquFDOwjjIWTdNnYChgTu4I9tiL90diBdDOVwh86io4QdOzjTtMJ7UYDx6dPTt-zNQ-KchIslj_eUTZoHAGVIVZYZnytf8hhFy-QLe90OzkLmULHgf-kddmGUgdWme8u78z8Kgf1Mp_5ibdq6QywFU0s1ZL7hKVlx9jVzsh23z6-THG1xnGrnJBn3fABw8LI_oYWkg08uFlrWlyDGnTUVPT1HBo-cSlU9oSWu_LkoNTHonxz8DwZ1657Qnx7_AZp-O2gnFwyoUICUdvKS9Axgq6s8UQ_CO2xtksLO9v7XbDcEXuhosnLZrWG5LZsCaAgPEctT7OLex5pLn1uoqUakpYwdphunYAu7j2kEdCxhQCq34TbJaN7W7TSg3MedSOONMJVSVlvBmC5aSVLFiVqQReQg_vJjLvvB2CU-LIJsCZVPMZBMRNpdKYYITc4ylMTq_0sai0teZD4_zi_dQ3Iui6IDbJzTjD0XQ50ILweMyrqD9CW59apugMWoBXwkFIDMi6_POcvphAIYAn0oY1yNyf5EN-oybNGXtmimUkVmsPNKNyK1Z31q0hAuwVkUCLVRLvW6pqcs59cFH7zM8Q091MrvzP77tLrnEkNnjmZDrZLUdT909gGat7pALaqjgmr_b75C1za1-_y3ce9t7r153_HIHXJ8Pk45Xy9_l0z-p |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB61RQIuiDeBAosEEodatffhTZAQokCVkrYXGiniYta7GygEu-RR4FbxF-B38KP6S5jZOA5BKLeebO3DmmQe-83u7AzAw6YVjre4jSyFikvtHdpBwaM09RJNg_D4pGiL_bTdla97qrcCv2d3YSiscmYTg6F2paU98k1cSHBtV6gTz46-RFQ1ik5XZyU0pmLR8d-_oss2errzEvn7iPPtVwcv2lFVVSDKEbqPI8tbznCLbgIiaydIoOOWi3OhRMu5vJ_o1JrYY5vleewQ0Ijc4xyH4EbJXAv87iqck3TEiPqje7re08GWllK8Sm6UiHQz__yRqmChLHKKolRNuqq_iq0Ly2CoFvA_iPtvpOZfS9_2ZbhUYVb2fCpkV2DFF1fh_F51Kn8NfryhbayBH22wtyWizWPzjR0bi52B7cwUjlEIOyv7bH5JC19DqJJ5wgwrwrYrs7imnp78rOLnWch9e3rya-hHk8F4xOguDEPEyrodtnWIlqj4xKjC73B8HbpnwoUbsFaUhb8FTNhYCCW99bYvdT81-GWHjpjSseZOpg14jH94VunmKAtuj0izijcZ8Sab8qYBfMaVzFY50qlUx2D5pI160tE0Rcjy4VvE7noo5fcODeXwfVaZiyyXKF8m7iP9CZ2s5i4hX9chfJMaMWwD1mfCMv9hcxVpwIO6G80FnQGZwpcTHKOasQ5AugE3p7JVUyIkOsMyQQr1gtQtkLrYUxx-CCnJm5QITzVvLyfrPlxoH-ztZrs7-507cJFTeFAIp1yHtfFw4u8ivhvn94JSMXh31lr8B5YdZCA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZ2kSZeEHc6BhgJJB4WNfUlF6QJUbZqo1BNQKWJl5DYDnSUZPQy4G3iL8Cv4mfsl3CO66QUob7tKZFjR07O7Tv28TmEPIwU1yxmylMYKi5Co0EPcuYFgRGgGriBK0Zb9IL9vnhxJI9WyO_qLAyGVVY60SpqXSpcI2-CIQHbLkEmmrkLizjc7Tw9-eJhBSncaa3KaaSuzILesenG3CGPrvn-Fdy58c7BLtD-EWOdvbfP9z1XccDLANZPPMVinTIFLgSgbs2R2f1Y-xmXPNY6y1thoFLfQJtima8B7PDMwBgNwEeKLOTw3lWyHoLVB0dwvb3XO3xdr_gAeIqlZC71UYsHzezzMdbIAk5lGGMpIzzIvwqtC0bS1hL4HwD-N47zL8PYuUIuO0RLn81Y8CpZMcU1svHK7dlfJz_e4CLX0Iy36bsSsOhp-o2ewt8bzNYhaVpoigHutMzp_AgX3NpApvQJTWlhF2WpAot7fvbTRddTmxn3_OzXyIynw8mY4kkZCniW9ru0PQA9VXyiWP93NLlB-hdCh5tkrSgLc5tQrnzOpTDKqFyEeZDCmzW4aTL0Q6ZF0CCP4YcnTnLHiXWKeJA42iRIm2RGmwZhFVUS5TKoYyGP4fJB2_Wgk1kCkeXd20juuitm_7YN5ehD4pRJkgnB_dTPYf4t3HfNdAs9YQ3gToSAcBtkq2KW-YfNBahBHtSPQZngDlFamHIKfWTkhxZmN8itGW_VM-ECXGXRghmGC1y3MNXFJ8Xgo01YHmGaPBltLp_WfbIBEp28POh175BLDGOHbKzlFlmbjKbmLoC_SXbPSRUl7y9akP8AAtBu-w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Shingles%2C+Zostavax+vaccination+and+risk+of+developing+dementia%3A+a+nested+case%E2%80%93control+study%E2%80%94results+from+the+UK+Biobank+cohort&rft.jtitle=BMJ+open&rft.au=Alistair+Burns&rft.au=Artitaya+Lophatananon&rft.au=Kenneth+Muir&rft.au=Rachel+Cant&rft.date=2021-10-08&rft.pub=BMJ+Publishing+Group&rft.eissn=2044-6055&rft.volume=11&rft.issue=10&rft_id=info:doi/10.1136%2Fbmjopen-2020-045871&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_b4430a0f2d414372bd14261d19047264 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2044-6055&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2044-6055&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2044-6055&client=summon |